XML 28 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders’ Deficit (Tables)
12 Months Ended
Dec. 31, 2020
Stockholders’ Deficit (Tables) [Line Items]  
Schedule of awards under our 2018 Incentive sock plan
As of December 31, 2020
   Share
Grants
Approved
   Options
Outstanding
   Shares
Available for
Award
 
2018 Incentive Stock Plan   50,000,000    20,150,000    29,850,000 
Total   50,000,000    20,150,000    29,850,000 
Schedule of fair value of warrant grant share-based awards at their grant date
   For the year ended
December 31,
 
   2020   2019 
Expected life (years)   N/A    5.5 - 6.75 
Dividend yield   N/A    0%
Expected volatility   N/A    232%
Risk free interest rates   N/A    2.47%
Weighted average fair value of options at grant date   N/A   $0.3400 
Schedule of activity of our stock options
   Shares   Weighted
Average
Exercise
Price
 
         
Outstanding at December 31, 2018   29,250,000   $0.1025 
Granted   6,650,000   $0.3545 
Exercised   -   $- 
Forfeited or expired   (3,000,000)  $0.2500 
Outstanding at December 31, 2019   32,900,000   $0.1400 
Granted   -   $- 
Exercised   (900,000)  $0.0700 
Forfeited or expired   -   $- 
Outstanding at December 31, 2020   32,000,000   $0.1419 
           
Exercisable at December 31, 2020   24,362,500   $0.1037 
Schedule of unrecognized stock-based compensation related to unvested restricted stock, net of estimated forfeitures
   Warrant Activity     
   Shares   Weighted
Average
Exercise Price
   Weighted
Average
Remaining
Contractual
Term (years)
 
Outstanding at December 31, 2018   -   $-      
                
Warrants Issued   3,675,000   $0.0632      
                
Outstanding at December 31, 2019   3,675,000   $0.0632      
                
Warrants Issued   50,000   $0.0500      
Warrants exercised   (175,000)  $0.0700      
                
Outstanding and exercisable at December 31, 2020   3,550,000   $0.0627    6.17 
Schedule of range exercise prices warrants outstanding and exercisable
   Warrants Outstanding   Warrants Exercisable 
       Weighted Avg.             
       Remaining             
   Shares   Contractual   Weighted Avg.   Shares   Weighted Avg. 
Range of Exercise Prices  Outstanding   Life in Years   Exercise Price   Exercisable   Exercise Price 
                     
$0.05 - $0.08   3,550,000    0.0627   $6.17    3,550,000   $6.17 
    3,550,000    0.0627   $6.17    3,550,000   $6.17 
Black-Scholes- Merton Option-Pricing Model [Member]  
Stockholders’ Deficit (Tables) [Line Items]  
Schedule of fair value of warrant grant share-based awards at their grant date
   For the year ended
December 31,
 
   2020   2019 
Expected life (years)   1.0    1.0 
Dividend yield   0%   0%
Expected volatility   125.19%   249%-149%
Risk free interest rates   0.14%   2.4-1.54%
Weighted average fair value of options at grant date  $.308   $0.0632